human induced pluripotent stem cell therapy (Evotec/Centogene)

N/A

Report date: 2025/03/20 15:34:32

Base Information

Drug Namehuman induced pluripotent stem cell therapy (Evotec/Centogene)
Drug Alias NameGaucher disease therapy (Evotec/Centogene)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesCentogene GmbhEvotec SE
Inactive CompaniesN/A
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A